Monday, 24th July Symposium on Proteases and the Tumouri Microenvironment 2017

TME has an active role in cancer progression - Gail Risbridger

Proteases are critical players in the TME - Judith Clements

Human rhomboid protease RHBDL2 regulates EGFR signalling in epithelial cells by the intramembrane cleavage of the EGF receptor - Nicholas A Johnson

Analysis of domain-specific interactions between Plasminogen and S100A10 - Blake Mazzitelli

Characterising the angiogenic potential of patient-derived stromal prostatic fibroblasts in a 3D in vitro model - Anthony Lighterness

The kallikrein-related peptidase 4 is involved in activation of prostate-derived stromal cells through the protease-activated receptor-1 - Thomas Kryza

Bioengineered microtissues enable analysis of the human prostatic tumour microenvironment in vitro - Brooke A Pereira

Significance of cathepsin B in gallbladder carcinogenesis - Siddharth Mehra

X-ray crystal structures of microplasmin in complex with sunflower trypsin inhibitor-1 (sfti-1) variants - Guojie Wu

Protease-controlled DARPin-toxin bioconjugates for tumor therapy - Hannes Merten

Stromal targeting of hyaluronic acid in patient-stratified models of pancreatic cancer - Claire Vennin

• Modular biohybrid hydrogels for mimicking tumor microenvironments in vitro - Carsten Werner
• A 3D patient-derived bioengineered model to investigate the stromal-epithelial-extracellular matrix interactions during prostate cancer initiation and progression - Elena M De-Juan-Pardo
• A 3D bioengineered mimic of the tumori microenvironment of ovarian cancer - Daniela Loessner
• Bioengineered microtissues enable analysis of the human prostatic tumour microenvironment in vitro - Brooke A Pereira
• Stromal targeting of hyaluronic acid in patient-stratified models of pancreatic cancer - Claire Vennin